Skip to main content

Initial Analysis of Viral Dynamics and Circulating Viral Variants During the mRNA-1273 Phase 3 COVE Trial

Acknowledgement:

...We also thank J. Grantham, J. Nutt, S. Cowden, K. Arnett, M. Wissel, C. Marti, S. Schildnecht and S. Kleiboeker, along with the staff of Eurofins Viracor BioPharma, for the development, validation and clinical trial sample analyses using SARS-CoV-2 RT–qPCR. With regards to generation of SARS-CoV-2 spike gene sequences, we thank T. Paprotka, T. Brefort, M. Schmitt, Y. Kumar, J. Nutt, S. Cowden, K. Murray, M. Diaz, M. Watters, C. Marti, E. Bixler, T. Moss and R. Sinha, along with the staff of Eurofins Viracor and Eurofins Genomics.

Back to top